ArticleJCO precision oncology2021

Debio1347, an Oral FGFR Inhibitor: Results From a Single-Center Study in Pediatric Patients With Recurrent or Refractory FGFR-Altered Gliomas.

Sameer Farouk Sait et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.